Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
Status:
Completed
Trial end date:
2020-08-17
Target enrollment:
Participant gender:
Summary
This study is intended to investigate the effect of candesartan, a blood pressure medication,
on cognitive function and thinking skills in those who have early or mild memory
difficulties, also called mild cognitive impairment or MCI.